Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCatenai Plc Regulatory News (CTAI)

Share Price Information for Catenai Plc (CTAI)

Share Price is delayed by 15 minutes
Get Live Data
0.235    -0.025 (-9.62%)
Bid:
0.22
Ask:
0.25
Spread: 0.03 (13.636%)
Market Cap: £3.37m
CTAI Live PriceLast checked at - London Stock Exchange

Intraday Catenai Plc Share Chart

Alludium VC Vertical Launch & Website Update

14 May 2026 07:00

RNS Number : 2409E
Catenai PLC
14 May 2026
 

14 May 2026

Catenai PLC

 

("Catenai", the "Company")

 

Alludium VC Vertical Launch & Website Update

 

Catenai PLC (AIM: CTAI), the AIM-quoted provider of technology and digital solutions, is pleased to provide an update on Alludium Ltd ("Alludium"), its investee company, following the public launch of Alludium's venture capital vertical and the associated relaunch of its website at alludium.ai.

 

Background

 

Since Alludium's commercial platform launch in March 2026, the company has been executing a go-to-market strategy focused on the venture capital ("VC") sector, its first targeted vertical. This follows a period of close collaboration with Sure Valley Ventures ("SVV"), a UK and Ireland-focused AI venture capital firm, which has been acting as a key design partner in shaping the VC-focused offering.

 

VC Vertical Launch

 

Alludium has today relaunched its website at alludium.ai to reflect its initial market positioning as an AI execution platform purpose-built for venture capital. The updated website describes Alludium's offering to investment teams: AI agents that perform the analytical work central to deal processes - company research, deal screening, diligence preparation, IC memo drafting, meeting support, and pipeline management - organised within a project and task management layer that keeps investment teams aligned across every active deal.

 

The platform is designed to work with data sources and tools that VC teams typically use, including Affinity, Harmonic, Dealroom, Pitchbook, Perplexity and Exa, providing a single execution layer across the deal lifecycle. All agent outputs are designed to provide traceability, with insights linked back to its source.

 

The VC vertical represents the first commercial packaging of the Alludium platform for a specific sector. The underlying platform architecture is unchanged and is designed to be replicated across additional verticals. Alludium believes the venture capital sector - high deal volume, time-pressured decisions, and significant analytical work that still moves manually between people and tools - is the right initial target market from which to build a repeatable go-to-market model.

 

John Frizelle, Founder & CEO of Alludium, commented:

 

"The VC vertical launch marks our transition from a platform-first story to commercialisation. The VC stack records the deal - but it does not move the deal. CRMs, data tools and AI assistants all sit beside the workflow. Alludium sits inside it. We have a clear customer in VC funds, a proof point already running on live deals, and a go-to-market motion in execution."

 

The person who arranged for release of this announcement on behalf of the Company was John Farthing, Interim Chief Executive Officer of the Company and the Directors of the Company are responsible for the release of this announcement.

 

For further information please contact:

 

Catenai PLC

+44 (0)20 7183 8666

John Farthing, Interim Chief Executive Officer

 

Shard Capital Partners LLP (Broker)

 

+44 (0)20 7186 9952

Damon Heath

Yellow Jersey PR

+44 (0) 20 3004 9512

Charles Goodwin / Ryan Forecast

 

Notes to Editors:

 

About Catenai PLC

Catenai is an AIM quoted provider of digital media and technology services. The Company has an experienced IT team of project managers and integrators who have deployed systems across corporate, government and educational sectors.

www.catenaiplc.com

 

Caution regarding forward looking statements

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABXLLFQELXBBZ
12
Date   Source Headline
22nd May 20267:00 amRNSKlarian Update and Webinar
14th May 20267:00 amRNS-RAlludium VC Vertical Launch & Website Update
20th Apr 20267:00 amRNSContract Renewal and Klarian Update
2nd Apr 20267:00 amRNS-RAlludium Achieves Certifications
19th Mar 20267:00 amRNSAlludium secures first paying customers
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
19th Feb 20267:00 amRNS-RUpdate re Alludium
20th Jan 20267:00 amRNS-RNew Company Website
19th Jan 202612:32 pmRNSHolding(s) in Company
5th Jan 20267:00 amRNSKlarian update
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
11th Dec 20257:00 amRNS-RInvestor Presentation
1st Dec 20257:00 amRNS-RAlludium Update
11th Nov 20257:00 amRNS-RAlludium launches new website
4th Nov 20257:00 amRNSRepayment of Loan & Issue of Warrants
30th Oct 20257:00 amRNSAlludium Commercial Launch
30th Sep 20257:00 amRNSHalf-year Report
15th Sep 20257:00 amRNS-RSVV featuring Alludium in AI Webinar series
28th Jul 20257:00 amRNSUpdate on Treasury
17th Jul 20257:00 amRNSInvestment in Alludium
15th Jul 20253:15 pmRNSResult of GM & Issue of Equity
7th Jul 20257:00 amRNSAlludium “First Look” Event
1st Jul 20257:00 amRNSNotice of GM & Further Re Fundraise
30th Jun 20257:00 amRNSFinal Results & Klarian Update
26th Jun 20257:54 amRNSFundraise of up to £1.6m
16th Jun 20257:00 amRNS-RAlludium 'First Look' Investor Event in London
9th Jun 20257:00 amRNSAlludium Strategic Program Update
27th May 20257:00 amRNSAlludium accepted into NVIDIA Inception
21st May 20257:00 amRNSFurther re investment in Alludium, Issue of Equity
15th May 20257:30 amRNSLaunch of Alludium at LangChain’s AI Conference
13th May 20257:10 amRNSInvestment in Alludium
12th May 20251:23 pmRNSResult of AGM, Issue of Equity, Warrants
6th May 202510:37 amRNSProposed Issue of Warrants
30th Apr 20253:30 pmRNSInsurance Policy Renewal
29th Apr 20251:00 pmRNSExercise of Warrant
17th Apr 20253:34 pmRNSNotice of AGM & Proposed Share Sub-division
11th Apr 20257:00 amRNSProposed Investment in Alludium, Fundraise
8th Apr 202512:30 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSKlarian update
25th Mar 20257:00 amRNSDirector Disclosure Update
17th Jan 202511:58 amRNSHolding(s) in Company
16th Jan 202510:27 amRNSHolding(s) in Company
14th Jan 202512:37 pmRNSWorking Capital Loan and Related Party Transaction
13th Jan 202510:39 amRNSKlarian CLN Update
29th Nov 20247:00 amRNSInsurance Policy Renewal & RPT
28th Oct 20247:00 amRNSKlarian update
20th Sep 20247:00 amRNSHalf-year Report
28th Jun 20247:00 amRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.